TTK Healthcare Limited (TTKHLTCARE.NS)

INR 1456.8

(-2.39%)

Total Debt Summary of TTK Healthcare Limited

  • TTK Healthcare Limited's latest annual total debt in 2023 was 228.1 Million INR , down -16.53% from previous year.
  • TTK Healthcare Limited's latest quarterly total debt in 2024 Q1 was - INR , down -100.0% from previous quarter.
  • TTK Healthcare Limited reported annual total debt of 273.28 Million INR in 2022, up 23.03% from previous year.
  • TTK Healthcare Limited reported annual total debt of 222.12 Million INR in 2021, up 16.03% from previous year.
  • TTK Healthcare Limited reported quarterly total debt of 301.12 Million INR for 2024 Q2, down 0.0% from previous quarter.
  • TTK Healthcare Limited reported quarterly total debt of - INR for 2023 Q3, down -100.0% from previous quarter.

Annual Total Debt Chart of TTK Healthcare Limited (2023 - 2004)

Historical Annual Total Debt of TTK Healthcare Limited (2023 - 2004)

Year Total Debt Total Debt Growth
2023 228.1 Million INR -16.53%
2022 273.28 Million INR 23.03%
2021 222.12 Million INR 16.03%
2020 191.43 Million INR -35.84%
2019 298.37 Million INR 4.54%
2018 285.42 Million INR -39.9%
2017 474.87 Million INR 107.61%
2016 228.73 Million INR -40.56%
2015 384.82 Million INR -7.75%
2014 417.13 Million INR 32.42%
2013 315.01 Million INR 40.62%
2012 224.01 Million INR 24.32%
2011 180.18 Million INR 45.22%
2010 124.08 Million INR -13.1%
2009 142.79 Million INR -5.8%
2008 151.58 Million INR 14.56%
2007 132.31 Million INR -3.78%
2006 137.5 Million INR 1.44%
2005 135.55 Million INR -33.56%
2004 204.02 Million INR 0.0%

Peer Total Debt Comparison of TTK Healthcare Limited

Name Total Debt Total Debt Difference
Abbott India Limited 832.3 Million INR 72.593%
Cipla Limited 5.59 Billion INR 95.922%
Gland Pharma Limited 3.72 Billion INR 93.871%
GlaxoSmithKline Pharmaceuticals Limited 186.65 Million INR -22.211%
Kopran Limited 992.28 Million INR 77.012%
Marksans Pharma Limited 2.44 Billion INR 90.654%
NGL Fine-Chem Limited 324.42 Million INR 29.689%
Pfizer Limited 945.4 Million INR 75.872%
Sanofi India Limited 190 Million INR -20.056%
SMS Pharmaceuticals Limited 2.8 Billion INR 91.876%